TY - JOUR
T1 - Active surveillance for small renal masses in elderly patients does not increase overall mortality rates compared to primary intervention
T2 - a propensity score weighted analysis
AU - Marchioni, Michele
AU - Cheaib, Joseph G.
AU - Takagi, Toshio
AU - Pavan, Nicola
AU - Antonelli, Alessandro
AU - Everaerts, Wourter
AU - Heck, Matthias
AU - Rha, Koon H.
AU - Mottrie, Alexandre
AU - Kaouk, Jihad
AU - Capitanio, Umberto
AU - Lima, Estevão
AU - Veccia, Alessandro
AU - Crivellaro, Simone
AU - Linares, Estefania
AU - Celia, Antonio
AU - Porpiglia, Francesco
AU - Autorino, Riccardo
AU - Di Nicola, Marta
AU - Schips, Luigi
AU - Pierorazio, Phillip M.
AU - Mir, Maria Carmen
N1 - Publisher Copyright:
© 2020 EDIZIONI MINERVA MEDICA.
PY - 2022
Y1 - 2022
N2 - BACKGROUND: The aim of the study was to test the effect of active surveillance (AS) versus primary intervention (PI) on overall mortality (OM) in elderly patients diagnosed with SRM. METHODS: Elderly patients (75 years or older) diagnosed with SRMs (<4 cm) and treated with either PI (i.e. partial nephrectomy or kidney ablation) or AS between 2009 and 2018 were abstracted from the renal surgery in the elderly (RESURGE) and Delayed Intervention and Surveillance for small Renal Masses (DISSRM) datasets, respectively. OM rates were estimated among groups with Kaplan Meier method and Cox proportional hazards regression models after applying inverse probability of treatment weighting (IPTW). Multivariable logistic regression model was used to estimate IPTW. Covariates of interest were those unbalanced and/or significantly correlated with the treatment choice or with OM. RESULTS: A total of 483 patients were included; 121 (25.1%) underwent AS. Sixty patients (12.4%) died. Overall, 6.7% of all deaths were related to cancer. IPTW-Kaplan Meier curves showed a 5-year overall survival rates of 70.0±3.5% and 73.2±4.8% in AS and PI groups, respectively (IPTW-Log-rank P value=0.308). IPTW-Cox regression model did not show meaningfully increased OM rates in AS group (HR: 1.31, 95% CI: 0.69-2.49). CONCLUSIONS: AS represents an appealing treatment option for very elderly patients presenting with SRM, as it avoids the risks of a PI while not compromising the survival outcomes of these patients.
AB - BACKGROUND: The aim of the study was to test the effect of active surveillance (AS) versus primary intervention (PI) on overall mortality (OM) in elderly patients diagnosed with SRM. METHODS: Elderly patients (75 years or older) diagnosed with SRMs (<4 cm) and treated with either PI (i.e. partial nephrectomy or kidney ablation) or AS between 2009 and 2018 were abstracted from the renal surgery in the elderly (RESURGE) and Delayed Intervention and Surveillance for small Renal Masses (DISSRM) datasets, respectively. OM rates were estimated among groups with Kaplan Meier method and Cox proportional hazards regression models after applying inverse probability of treatment weighting (IPTW). Multivariable logistic regression model was used to estimate IPTW. Covariates of interest were those unbalanced and/or significantly correlated with the treatment choice or with OM. RESULTS: A total of 483 patients were included; 121 (25.1%) underwent AS. Sixty patients (12.4%) died. Overall, 6.7% of all deaths were related to cancer. IPTW-Kaplan Meier curves showed a 5-year overall survival rates of 70.0±3.5% and 73.2±4.8% in AS and PI groups, respectively (IPTW-Log-rank P value=0.308). IPTW-Cox regression model did not show meaningfully increased OM rates in AS group (HR: 1.31, 95% CI: 0.69-2.49). CONCLUSIONS: AS represents an appealing treatment option for very elderly patients presenting with SRM, as it avoids the risks of a PI while not compromising the survival outcomes of these patients.
UR - http://www.scopus.com/inward/record.url?scp=85124497799&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85124497799&partnerID=8YFLogxK
U2 - 10.23736/S2724-6051.20.03785-6
DO - 10.23736/S2724-6051.20.03785-6
M3 - Article
C2 - 32993273
AN - SCOPUS:85124497799
VL - 73
SP - 781
EP - 788
JO - Minerva Urology and Nephrology
JF - Minerva Urology and Nephrology
SN - 2724-6051
IS - 6
ER -